Delays put 40-year-old global HIV medicine-testing group at risk

Money for Advancing Clinical Therapeutics Globally, a 40-year-old worldwide group that tests HIV medicines, is at risk from paperwork delays, the New York Times reported Oct. 7, 2026. It comes after deep Trump administration cuts to aid for fighting HIV abroad. Long breaks make it hard to bring patients back and keep tracking results.